Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains

Antimicrob Agents Chemother. 1995 Jan;39(1):250-2. doi: 10.1128/AAC.39.1.250.

Abstract

In 4 of 17 Helicobacter pylori strains obtained from antral biopsy samples, the registered primary resistance (MIC, > 32 microgram/ml) appeared to be nonstable after prolonged microaerophilic incubation. In all resistant strains tested, susceptibility could be obtained when culture under normal microaerophilic conditions was preceded by a period of anaerobic incubation. Both of these findings may explain the observed discrepancy between the results of in vitro susceptibility tests and the eradication obtained in vivo.

MeSH terms

  • Antacids / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use*
  • Bismuth / therapeutic use*
  • Drug Resistance, Microbial
  • Helicobacter Infections / drug therapy
  • Helicobacter pylori / drug effects*
  • Humans
  • Metronidazole / pharmacology*
  • Microbial Sensitivity Tests

Substances

  • Antacids
  • Anti-Bacterial Agents
  • Metronidazole
  • bismuth subnitrate
  • Bismuth